Intas launches DCGI-approved Tofacitinib Topical
Ahmedabad, June 2023. Intas Pharmaceuticals Ltd., one of India’s leading pharmaceutical companies with operations across the globe has launched TOFATAS – a DCGI-approved, Tofacitinib Ointment 2% w/w for the treatment of mild to moderate Atopic Dermatitis (AD) in patients 18 years and above having flare-ups of the disease. Atopic Dermatitis (AD) is a chronic inflammatory,…